Volume 9, issue 1, December 2024
45 articles in this issue
-
-
eTFC-01: a dual-labeled chelate-bridged tracer for SSTR2-positive tumors
Authors (first, second and last of 7)
-
In vitro and in vivo evaluation of a tetrazine-conjugated poly-L-lysine effector molecule labeled with astatine-211
Authors (first, second and last of 6)
-
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Authors (first, second and last of 24)
-
[68Ga]Ga-NODAGA-TriGalactan, a low molecular weight tracer for the non-invasive imaging of the functional liver reserve
Authors (first, second and last of 9)
-
Good practices for 89Zr radiopharmaceutical production and quality control
Authors (first, second and last of 4)
This is part of 1 collection:
-
Automated synthesis of [89Zr]ZrCl4, [89Zr]ZrDFOSquaramide-bisPh(PSMA) and [89Zr]ZrDFOSquaramide-TATE
Authors (first, second and last of 6)
-
Bifunctional octadentate pseudopeptides as Zirconium-89 chelators for immuno-PET applications
Authors (first, second and last of 12)
-
Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape
Authors (first, second and last of 4)
-
99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications
Authors (first, second and last of 5)
-
GMP production of [18F]FE-PE2I on a TRACERLab FX2 N synthesis module, a radiotracer for in vivo PET imaging of the dopamine transport
Authors (first, second and last of 11)
-
Advancing 6-bromo-7-[11C]methylpurine to clinical use: improved regioselective radiosynthesis, non-clinical toxicity data and human dosimetry estimates
Authors (first, second and last of 10)
-
Small animal PET imaging with the 68Ga-labeled pH (low) insertion peptide-like peptide YJL-4 in a triple-negative breast cancer mouse model
Authors (first, second and last of 7)
-
Radiolabeled 15-mer peptide internalization is mediated by megalin (LRP2 receptor) in a CRISPR/Cas9-based LRP2 knockout human kidney cell model
Authors (first, second and last of 8)
-
Automated radiolabelling of [68Ga]Ga-PSMA-11 (gallium (68Ga)-gozetotide) using the Locametz® kit and two generators
Authors (first, second and last of 5)
-
Comparison of approaches for increasing affinity of affibody molecules for imaging of B7-H3: dimerization and affinity maturation
Authors (first, second and last of 6)
-
Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trial
Authors (first, second and last of 12)
-
Improved automated one-pot two-step radiosynthesis of (S)-[18F]FETrp, a radiotracer for PET imaging of indoleamine 2,3-dioxygenase 1 (IDO1)
Authors (first, second and last of 7)
-
Human biodistribution and radiation dosimetry for the tau tracer [18F]Florzolotau in healthy subjects
Authors (first, second and last of 5)
-
In vivo evaluation of tumor uptake and bio-distribution of 99mTc-labeled 1-thio-β-D-glucose and 5-thio-D-glucose in mice model
Authors (first, second and last of 13)
-
Expanding a peptide-covalent probe hybrid for PET imaging of S. aureus driven focal infections
Authors (first, second and last of 8)
-
In-target production of [11C]CH4 from a nitrogen/hydrogen gas target as a function of beam current, irradiation time, and target temperature
Authors (first, second and last of 6)
-
Validation of a size exclusion method for concomitant purification and formulation of peptide radiopharmaceuticals
Authors (first, second and last of 5)
-
Correction: Physiologically based radiopharmacokinetic (PBRPK) modeling to simulate and analyze radiopharmaceutical therapies: studies of non-linearities, multi-bolus injections, and albumin binding
Authors (first, second and last of 4)
-
Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET
Authors (first, second and last of 9)
-
Preclinical characterisation of gallium-68 labeled ferrichrome siderophore stereoisomers for PET imaging applications
Authors (first, second and last of 7)
-
A novel PET probe to selectively image heat shock protein 90α/β isoforms in the brain
Authors (first, second and last of 15)
-
Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies
Authors (first, second and last of 9)
-
Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics
Authors (first, second and last of 12)
-
Radiosynthesis, structural identification and in vitro tissue binding study of [18F]FNA-S-ACooP, a novel radiopeptide for targeted PET imaging of fatty acid binding protein 3
Authors (first, second and last of 11)
-
Optimization and scale up of production of the PSMA imaging agent [18F]AlF-P16-093 on a custom automated radiosynthesis platform
Authors (first, second and last of 7)
-
Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands
Authors
-
Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology
Authors (first, second and last of 8)
-
Intranasal administration enhances size-dependent pulmonary phagocytic uptake of poly(lactic-co-glycolic acid) nanoparticles
Authors (first, second and last of 7)
-
Validation of an automated dispensing system for subsequent dose dispensing of different radionuclides
Authors (first, second and last of 4)
-
Improved synthesis of 6-bromo-7-[11C]methylpurine for clinical use
Authors (first, second and last of 4)
-
Implementing Ac-225 labelled radiopharmaceuticals: practical considerations and (pre-)clinical perspectives
Authors (first, second and last of 7)
This is part of 1 collection:
-
Unnatural amino acid substitutions to improve in vivo stability and tumor uptake of 68Ga-labeled GRPR-targeted TacBOMB2 derivatives for cancer imaging with positron emission tomography
Authors (first, second and last of 10)
-
A novel PSMA-targeting tracer with highly negatively charged linker demonstrates decreased salivary gland uptake in mice compared to [68Ga]Ga-PSMA-11
Authors (first, second and last of 4)
-
Physiologically based radiopharmacokinetic (PBRPK) modeling to simulate and analyze radiopharmaceutical therapies: studies of non-linearities, multi-bolus injections, and albumin binding
Authors (first, second and last of 4)
-
Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer model
Authors (first, second and last of 6)
-
Cu(II)-Mediated direct 18F-dehydrofluorination of phosphine oxides in high molar activity
Authors (first, second and last of 5)
-
Production of the PET radionuclide 61Cu via the 62Ni(p,2n)61Cu nuclear reaction
Authors (first, second and last of 4)
-
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework
Authors (first, second and last of 15)
-
Preclinical evaluation of an 18F-labeled Nε-acryloyllysine piperazide for covalent targeting of transglutaminase 2
Authors (first, second and last of 9)
